1
Orphan Designations
0
FDA Approvals
8
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| Matthew-Wood syndrome | Letairis | Orphan Designation | - |
| anophthalmia/microphthalmia-esophageal atresia syndrome | Letairis | Orphan Designation | - |
| drug- or toxin-induced pulmonary arterial hypertension | Letairis | Orphan Designation | - |
| familial pulmonary arterial hypertension leucopenia and atrial septal defect | Letairis | Orphan Designation | - |
| global developmental delay-osteopenia-ectodermal defect syndrome | Letairis | Orphan Designation | - |
| heritable pulmonary arterial hypertension | Letairis | Orphan Designation | - |
| idiopathic pulmonary arterial hypertension | Letairis | Orphan Designation | - |
| pulmonary arterial hypertension | Letairis | Orphan Designation | - |